Breaking News

Valitacell, Solentim Form Biologics Collaboration

Goal is to enable earlier identification of biological candidates

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Valitacell, a biotech offering cell-based manufacturing, and Solentim, a provider of cell line development instrumentation, have formed a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines.   Valitacell’s novel in-line analytical profiling technologies and its data driven/machine learning approach, together with Solentim’s innovative image-driven liquid handling and cell measurement technology, will look to tran...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters